Customer List

“R&D Manage is a sophisticated, flexible management tool that allows us to identify, manage, and prioritize resources by giving us the ability to track and forecast by project as well as by overall P&L.”
                       -- Roche Palo Alto

Our customers use R&D Manage and R&D Time as their corporate budgeting, forecasting and tracking solution. Each deployment is fully integrated with local accounting and payroll systems, and, in some cases, with purchasing and time reporting systems. Finance, management and project leaders use R&D Manage to proactively plan and measure the business performance of their respective areas of responsibility.

• Roche Palo Alto, LLC.
• Cytokinetics, Inc.
• Metabolex, Inc.
• Nuvelo, Inc.
• Pharmos Corporation
• Neurogen Corporation
• Novacea, Inc.
• NPS Pharmaceuticals, Inc.
• Epix Pharmaceuticals, Inc.
• Avigen, Inc.
• Adamas Pharmaceuticals, Inc.
• Titan Pharmaceuticals, Inc.
• InterMune, Inc.
• Momenta Pharmaceuticals, Inc.
• Alnylam Pharmaceuticals, Inc.
• SGX Pharmaceuticals, Inc.
• FivePríme Therapeutics, Inc.
• Kalypsys, Inc.
• Via Pharmaceuticals, Inc.
• Catalyst Biosciences
• Savient Pharmaceuticals
• Tercica, Inc.
• Neurobiological Technologies
• Ambrx, Inc.
• Portola Pharmaceuticals, Inc.
• Nevro Corporation
• Medivation, Inc.
• KaloBios Pharmaceuticals, Inc.
• Inviragen, Inc.
• Facet Biotech Corporation
• MacroGenics, Inc.
• Hyperion Therapeutics, Inc.
• Prognosys Biosciences
• Trius Therapeutics
• Athersys, Inc.
• Anthera Pharmaceuticals, Inc.
• NovaBay Pharmaceuticals, Inc.
• Affymax, Inc.
• VitaPath Genetics, Inc.
• ReadlD Inc.

Roche Palo Alto discovers and develops prescription drugs in key therapeutic areas such as diseases of the nervous system, virology, infectious diseases, oncology, cardiovascular diseases, inflammatory and autoimmune diseases, dermatology, metabolic disorders and respiratory diseases.
Top

Cytokinetics Inc. Cytokinetics is a clinical-stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions.
Top

Metabolex, Inc. discovers and develops new drugs for type 2 diabetes and brings to market novel drugs with distinct and complementary modes of action, to address the full range of defects underlying diabetes.
Top

Nuvelo, Inc. formed by the merger of Hyseq Pharmaceuticals, Inc. and VARIAGENICS, Inc., is focused on the discovery and development of therapeutics that improve life.
Top

Pharmos Corporation is a bio-pharmaceutical company focused on the discovery, development and commercialization of therapeutics for the central and peripheral nervous systems, and ophthalmologic, cardiovascular and inflammation-related indications.
Top

Neurogen Corporation is a leader in both the discovery and development of new drug candidates and in the development and integration of new drug discovery technologies, most notably its AIDD (Accelerated Intelligent Drug Discovery) system.
Top

Novacea, Inc. is a rapidly growing drug development company that has the exclusive worldwide rights to the Oregon Health & Science University (OHSU) technology for dose and a method of use of calcitriol and its analogs, potentially providing a major breakthrough in the treatment of cancer.
Top

NPS Pharmaceuticals, Inc. is engaged in the discovery and development of novel, small molecule drugs and recombinant peptides that address a variety of important diseases.
Top

EPIX Pharmaceuticals, Inc. 's goal is to transform the management and diagnosis of vascular disease through the development of targeted MRI contrast agents.
Top

Avigen, Inc. is commited to providing physicians and their patients with innovative therapeutics for the treatment of neurological conditions.
Top

Adamas Pharmaceuticals, Inc. is developing superior neuroprotective medicines for the treatment of central nervous system disorders.
Top

Titan Pharmaceuticals, Inc. (AMEX: TTP) is a biopharmaceutical company focused on the development and commercialization of novel treatments for central nervous system disorders, cardiovascular disease, bone disease and other disorders.
Top

Intermune, Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies in pulmonology and hepatology.
Top

Momenta Pharmaceuticals, Inc. is a biotechnology company specializing in the detailed structural analysis and design of complex sugars for the development of improved versions of existing drugs, the development of novel drugs, and the discovery of new biological processes.
Top

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutics based on a breakthrough discovery that enables the creation of a broad new class of human therapeutics.
Top

SGX Pharmaceuticals, Inc. is a biotechnology company focused on the discovery, development and commercialization of innovative cancer therapeutics.
Top

FivePríme Therapeutics, Inc. is developing treatments for cancer and diabetes and multiple leads in metabolic and immunologic diseases, oncology and regenerative medicine.
Top
 

Kalypsys, Inc. is developing breakthrough therapies for some of the world's most widespread diseases including cardiovascular/metabolic diseases, pain/inflammation and oncology.
Top
 

Via Pharmaceuticals, Inc. is a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease. Their drug development pipeline consists of both pre-clinical and clinical-stage small molecule drugs that target various stages of vascular inflammation.
Top
 

Catalyst Biosciences is a leading biotechnology company focused on developing proteases as a therapeutic platform for inflammation, cardiovascular, and angiogenesis-based disorders.
Top
 

Savient Pharmaceuticals, Inc. is a specialty biopharmaceutical company engaged in developing and distributing pharmaceutical products that target unmet medical needs in both niche and broader markets.
Top
 

Tercica, Inc. is a biopharmaceutical company working to develop and commercialize therapeutics for growth and other endocrine disorders.
Top
 

Neurobiological Technologies, Inc. is a biotechnology company engaged in the business of acquiring and developing central nervous system (CNS) related drug candidates. The company is focused on therapies for neurological conditions that occur in connection with dementia, Alzheimer's disease, ischemic stroke, neuropathic pain, and brain cancer.
Top
 

Ambrx, Inc. is a biopharmaceutical company with a mission to deliver breakthrough protein therapeutics. Ambrx is based on a fundamental advance in protein biosynthesis that enables the company to genetically engineer proteins with new amino acid building blocks beyond the common twenty, enabling the biosynthesis of proteins with new physical, chemical and pharmacological properties.
Top
 

Portola Pharmaceuticals, Inc. is discovering and developing novel therapeutics to meet patient needs in cardiovascular, inflammation, and oncology indications.
Top
 

Nevro Corporation is a medical device company developing novel neuromodulation therapies for multiple indications. The company's initial focus is the development of an implantable device for the treatment of chronic pain.
Top
 

Medivation, Inc. is a biopharmaceutical company with small molecule drugs in clinical development to treat three large, unmet medical needs—Alzheimer’s disease, Huntington’s disease and castration-resistant prostate cancer.
Top
 

KaloBios Pharmaceuticals, Inc. , a U.S. based, private monoclonal company, uses its biologic capabilities and its proprietary platform technology to develop first-in-class human antibody therapeutics.
Top
 

Inviragen, Inc. , is focused on developing life-saving vaccines to protect against emerging infectious diseases worldwide. Inviragen's lead product is a vaccine to protect against dengue fever, a disease that threatens 2.5 billion people across the globe.
Top
 

Facet Biotech Corporation combines expertise in antibody engineering with a disciplined, biology-driven research approach. Facet Biotech is dedicated to advancing their current pipeline of four clinical-stage products and leveraging their research and development capabilities to identify and develop new drugs.
Top
 

MacroGenics, Inc. , is focused on applying its world-class antibody capabilities to discover, develop and deliver to patients novel biologics for the treatment of autoimmune disorders, cancer and infectious diseases.
Top
 

Hyperion Therapeutics, Inc. , is a privately held pharmaceutical company focused on the development of treatments that address critical unmet needs in the areas of gastroenterology and hepatology.
Top
 

Prognosys Biosciences is an early-stage biotechnology company focusing on the promising and rapidly developing field of personalized medicine. Prognosys carries out R&D in the area of novel assays and biomarker discovery, and uses next-generation sequencing technologies for the analysis of complex systems.
Top
 

Trius Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics for serious, life-threatening infections
Top
 

Athersys, Inc. is a biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. Through the application of our proprietary technologies, we have established a pipeline of therapeutic product development programs in multiple disease areas.
Top
 

Anthera Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products to treat serious illnesses, including cardiovascular and autoimmune diseases.
Top
 

NovaBay Pharmaceuticals is a clinical stage biotechnology company focused on developing its proprietary and patented topical Aganocide compounds, which are novel, synthetic anti-infective product candidates with equivalent activity to the active antimicrobial molecules generated within white blood cells.
Top
 

Affymax is a biopharmaceutical company committed to developing novel drugs to improve the treatment of serious and often life-threatening conditions. The company's product candidate, peginesatide (formerly known as HematideT), has been investigated in Phase 3 trials for the potential treatment of anemia associated with chronic renal failure.
Top
 

Vitapath Genetics, Inc. is developing a family of DNA tests to help individuals reduce the risk of serious and life-threatening disease.
Its first product is a genetic test to identify risk factors that are associated with a common birth defect called Spina Bifida and which can be safely corrected with low-risk vitamin supplementation under the care of a physician.
Top
 

RealD is a leading global licensor of stereoscopic (three-dimensional), or 3D, technologies. Its extensive intellectual property portfolio enables a premium 3D viewing experience in the theater, the home and elsewhere.
Top